Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1472-8206|30|5|459-465

ISSN： 0767-3981

Source： Fundamental & Clinical Pharmacology, Vol.30, Iss.5, 2016-10, pp. : 459-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis

By >   >   Navarro Amparo Sánchez   Dominguez-Gil Alfonso   >  

Clinical Pharmacokinetics, Vol. 48, Iss. 4, 2009-06 ,pp. : 273-280

Adis International

Access to resources Recommend Favorite

A pharmacokinetic/pharmacodynamic analysis of a standard voriconazole regimen in different CYP2C19 genotypes by Monte Carlo simulation

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 306-309

Govi-Verlag

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Profile of Voriconazole

By Theuretzbacher Ursula  

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson's Disease

By Neef C.  

Clinical Pharmacokinetics, Vol. 37, Iss. 3, 1999-09 ,pp. : 257-271

Adis International

Access to resources Recommend Favorite

Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody

By Duconge J.   Castillo R.   Crombet T.   Alvarez D.   Matheu J.   Vecino G.   Alonso K.   Beausoleil I.   Valenzuela C.   Becquer M.A.   Fernandez-Sanchez E.  

European Journal of Pharmaceutical Sciences, Vol. 21, Iss. 2, 2004-02 ,pp. : 261-270

Elsevier

Access to resources Recommend Favorite